Back

Notification report


Full notification file


General information

Notification Number
B/NL/11/002

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
07/04/2011

Title of the Project
Cancer immunotherapy of human papillomavirus-induced (pre)malignant lesion using replication-incompetent Semliki Forest Virus replicon particles encoding human papillomavirus antigens.

Proposed period of release:
01/01/2012 to 01/01/2022

Name of the Institute(s) or Company(ies)
University Medical Center Groningen, Hanzeplein 1
9713 GZ Groningen
PO Box 30.001
9700 RB Groningen
The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Togaviruses, Genus Alphavirus, Semliki Forest virus (SFV)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
SFVAlphavirusesSemliki Forest virus-SFV L10-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known